Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3051

Actual shortage: 226 (7%)
Anticipated shortage: 17 (1%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMOXI CLAV 250MG/62.5MG PER 5ML 250MG 62.5MG POWDER FOR SUSPENSION Resolved 2017-03-10 2019-05-13 49
APO-AMOXI CLAV 250MG 125MG TABLET Resolved 2020-01-15 2020-02-19 103357
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77855
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-20 2020-04-04 79039
APO-VERAP SR 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 255
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-12 2018-12-18 716
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-06-28 2018-12-18 14168
APO-DOCUSATE CALCIUM 240MG CAPSULE Actual shortage 2017-08-14 2017-10-05 19120
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-13 2019-07-12 75614
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-24 2019-07-12 76714
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-08-07 2019-10-15 91073
APO-DILTIAZ CD 240MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-09-04 2019-10-15 92965
APO-PREGABALIN 225MG CAPSULE Resolved 2017-08-08 2017-09-22 18553
APO-PREGABALIN 225MG CAPSULE Resolved 2021-04-16 2021-04-26 137595
APO-PREGABALIN 225MG CAPSULE Anticipated shortage 2024-01-19 2024-01-19 216729
APO-ELETRIPTAN 20MG TABLET Resolved 2017-03-10 2020-01-07 305
APO-FOSINOPRIL 20MG TABLET Resolved 2017-03-10 2017-04-10 324
APO-OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Resolved 2017-03-10 2017-04-04 408
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-03-11 2017-05-23 466
APO-SILDENAFIL R 20MG TABLET Resolved 2017-03-11 2017-08-24 507

Showing 1621 to 1640 of 3051

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-LOPERAMIDE 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155

Showing 121 to 140 of 356